The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial
Official Title: Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial
Study ID: NCT00630188
Brief Summary: The purpose of this study is to determine whether an intervention designed to help men share decisions about prostate cancer screening with their physician results in better decision making, more shared decisions, and changes in intended and actual screening rates.
Detailed Description: Background: Professional societies recommend shared decision making for prostate cancer screening, however, most effort has been directed at informed rather than shared decision making. In this study, we plan to test the effects of a shared decision making intervention on key components of shared decision making. We secondarily plan to test its effects on the presence of a shared decision, men's intention to be screened, and actual screening rates. Methods: We plan to conduct two separate randomized controlled trials of shared decision making interventions, one in which the intervention focuses on prostate cancer screening only and one in which the intervention focuses on prostate cancer screening in the context of other men's health issues. Each trial will use the same attention control and identical implementation and measurement strategies to allow combination of data if no differences exist in the effect of the interventions. Trials will include a convenience sample of men with no prior history of prostate cancer who present to their primary care physician for routine care. Men will be randomly assigned to a shared decision making intervention (including a video and coaching session for patients and an education session for providers) or a control group, in which men will receive a video on highway safety. Data on key components of shared decision making and intent for screening will be measured at baseline, after the intervention, and after men's visit with their provider. Additionally, medical charts will be reviewed 9 months later to assess for actual screening.
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Chapel Hill North General Internal Medicine Practice, Chapel Hill, North Carolina, United States
University of North Carolina at Chapel Hill General Medicine Clinic, Chapel Hill, North Carolina, United States
Moses Cone Internal Medicine Practice, Greensboro, North Carolina, United States
Triad Internal Medicine, Greensboro, North Carolina, United States
Name: Russ Harris, MD, MPH
Affiliation: University of North Carolina, Chapel Hill
Role: PRINCIPAL_INVESTIGATOR
Name: Lauren McCormack, PhD, MSPH
Affiliation: RTI International
Role: PRINCIPAL_INVESTIGATOR
Name: David Driscoll, PhD, MSPH
Affiliation: RTI International
Role: PRINCIPAL_INVESTIGATOR